Research Article

Expression of Myeloid Antigen in Neoplastic Plasma Cells Is Related to Adverse Prognosis in Patients with Multiple Myeloma

Figure 2

Kaplan-Meier analysis of (a) progression free survival (PFS) and (b) overall survival (OS) in groups of patients positive and negative for CD33 and CD13. CD33 expression demonstrates a potential prognostic impact and was associated with lower OS ( ). Patients with CD13 associated with significantly shorter PFS times ( ), not only lower OS ( ).
893243.fig.002a
(a)
893243.fig.002b
(b)